Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TBPH compared with AIV: revenue, margins and what each company keeps, and the suppliers and customers both name
TBPH
Theravance Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
AIV
Apartment Investment & Management Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
TBPH
Theravance Biopharma, Inc.
vs
AIV
Apartment Investment & Management Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TBPH, solid
AIV, dashed
Supply-chain overlap
Revenue flow
TBPH: latest quarter is a loss; flow not drawable. AIV: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TBPH
6
VTRS
Viatris
supplier
LAZ
Lazard
supplier
GSK
GSK
customer
RPRX
Royalty Pharma Investments
customer
2 more · TBPH chain
›
Shared
0
No disclosed counterparties: AIV.
Only AIV
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
TBPH
Theravance Biopharma, Inc.
Change
17.03
▲
+0.02%
· post 17.04
Mkt cap
$884.2M
Revenue
$21M
Q2 FY26
Revenue
$107M
FY25
AIV
Apartment Investment & Management Co
Change
1.57
▼
−4.27%
· post 1.57
Closed
Oct 30 '26
Mkt cap
$228.0M
Revenue
$35M
Q3 FY25
Revenue
$138M
FY24
vs
Compare
Closed
Oct 30 '26
TBPH
Theravance Biopharma, Inc.
vs
AIV
Apartment Investment & Management Co
17.03
▲
+0.02%
post 17.04
Price
1.57
▼
−4.27%
post 1.57
$884.2M
Mkt cap
$228.0M
Q2 FY26
$21M
Revenue
$35M
Q3 FY25
FY25
$107M
Revenue
$138M
FY24
Change
Change
TBPH
17.03
▲
+0.02%
vs
AIV
1.57
▼
−4.27%
Closed
Oct 30 '26